Phase II trial of panitumumab with irinotecan as salvage therapy for patients with advanced or recurrent colorectal cancer (TOPIC study)

Little is known about the clinical impact of salvage panitumumab with irinotecan for metastatic colorectal cancer (mCRC) patients. The present study conducted a single-arm, multicenter phase II trial for mCRC with skin toxicity prevention program. The subjects were mCRC patients with wild-type KRAS,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: NISHI, TOMOHIRO, HAMAMOTO, YASUO, NAGASE, MICHITAKA, DENDA, TADAMICHI, YAMAGUCHI, KENSEI, AMAGAI, KENJI, MIYATA, YOSHINORI, YAMANAKA, YASUHIRO, YANAI, KAI, ISHIKAWA, TSUTOMU, KUROKI, YOSHIFUMI, FUJII, HIROFUMI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888220/
https://ncbi.nlm.nih.gov/pubmed/27313739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4532
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados